Edition:
United States

Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

76.33EUR
11:35am EST
Change (% chg)

€1.25 (+1.66%)
Prev Close
€75.08
Open
€75.32
Day's High
€76.95
Day's Low
€75.28
Volume
3,046,253
Avg. Vol
2,626,841
52-wk High
€80.90
52-wk Low
€62.50

Latest Key Developments (Source: Significant Developments)

Sanofi Genzyme begins pivotal phase 2/3 trial
Wednesday, 6 Jul 2016 08:00am EDT 

Sanofi SA :Sanofi Genzyme begins pivotal phase 2/3 trial of olipudase alfa for adult patients with acid sphingomyelinase deficiency.  Full Article

Sanofi raises Medivation offer, enters confidentiality agreement
Tuesday, 5 Jul 2016 04:28pm EDT 

Sanofi statement: Sanofi confirms it has entered into a confidentiality agreement with Medivation under which it will be provided due diligence access and confidential information. . Says that it advised Medivation that upon signing a confidentiality agreement and being provided information, it would increase its offer to $58.00 in cash $3.00 in form of a contingent value right (cvr) relating to talazoparib sales performance. . Says a dataroom will be opened and management meetings scheduled in near term. . Under the confidentiality agreement, Sanofi has agreed to a customary standstill for six months subject to limited early termination events and has agreed to withdraw its consent solicitation. .Sanofi is confident that its due diligence can be quickly completed and that if an agreement is reached on a mutually acceptable transaction, Sanofi can close promptly given that it has received U.S. regulatory clearance, and there would be no financing condition..  Full Article

Sanofi Genzyme says Saskatchewan has added Lemtrada to province's MS drugs program
Tuesday, 5 Jul 2016 08:00am EDT 

Sanofi Sa :Saskatchewan has added Lemtrada to province's MS drugs program for eligible people living with relapsing-remitting multiple sclerosis.  Full Article

Sanofi sounding out Medivation shareholders as it prepares to raise bid- CNBC
Tuesday, 28 Jun 2016 09:56am EDT 

CNBC (Bengaluru Newsroom:.  Full Article

Icagen acquires Sanofi's Oro Valley, Arizona research facility
Monday, 27 Jun 2016 04:00pm EDT 

Icagen: Acquires Sanofi's Oro Valley, Arizona research facility . Icagen says will retain majority of scientists working at Tucson site in transition .Icagen says value of deal was not disclosed.  Full Article

U.S. SEC accuses Christopher Plaford of insider trading, overstating fund's valuation
Wednesday, 15 Jun 2016 10:43am EDT 

Sanofi SA : U.S. SEC files civil lawsuit accusing christopher plaford of insider trading, overstating fund's net asset value -- court filing . SEC says plaford traded on inside information about FDA review of generic version of Sanofi sa's lovenox . SEC says plaford also used sham broker quotes to inflate value of securities in a fund he oversaw . SEC says plaford also conducted insider trading related to pending announcement of U.S. cut to medicare reimbursement rates . SEC says the unlawful trading resulted in about $285,000 illegal profit for funds linked to plaford.  Full Article

Sanofi announces expiration of Hart-Scott-Rodino waiting period for proposed acquisition of Medivation
Monday, 13 Jun 2016 12:09pm EDT 

Orege SA : First contract to sell an SLG mobile solution in England .Solution sold to Anglian Water.  Full Article

Sanofi files investor presentation with SEC on proposed acquisition of Medivation
Wednesday, 8 Jun 2016 06:32am EDT 

: Sanofi says filed investor presentation on proposed acquisition of Medivation with the U.S. Securities and Exchange Commission . Sanofi says its proposal is not subject to any financing condition, . Sanofi says it is confident in its ability to receive all regulatory approvals . Sanofi says its is willing to enter into customary confidentiality agreement which would include a standstill clause to give time for Medivation to conduct a sale process . Sanofi says the record date to determine Medivation shareholders entitled to give their written consent has been established as June 1 and expects the initial Hart-Scott-Rodino (HSR) waiting period to expire on June 13. . Sanofi says it anticipates filing definitive consent solicitation materials in mid-June . Sanofi says it has signed a consent on June 3 for the shares it owns in Medivation and therefore expects that the 60-day consent solicitation period will conclude no later than August 1 Further company coverage: [SASY.PA-E] (Paris Newsroom).  Full Article

Medivation sets record date for Sanofi's proposed consent solicitation
Wednesday, 1 Jun 2016 06:45pm EDT 

Medivation Inc : Medivation sets record date for Sanofi's proposed consent solicitation . Says accordance with Sanofi's request, company's board of directors has set close of business on June 1, 2016 .In accordance with request, co's board of directors has set close of business on June 1, as record date for Sanofi consent solicitation.  Full Article

Sanofi requests record date for consent solicitation to remove and replace Medivation's board
Wednesday, 1 Jun 2016 02:15pm EDT 

Sanofi SA : Latest day Medivation board can set record date is June 22, 2016 . Sanofi requests record date for consent solicitation to remove and replace Medivation's board of directors .Pursuant to terms of its bylaws, Medivation is required to adopt a resolution fixing record date within 10 calendar days of request.  Full Article

Photo

EU regulator accepts Sanofi/Regeneron's Dupixent product for review

PARIS The European Medicines Agency (EMA), the European Union's health regulator, has accepted for review the Dupixent product being developed by drugmakers Sanofi and Regeneron, the companies said on Thursday.